Helpdesk

Sales contact

Home > Resources > Working with patient associations: What is the key to a positive interaction?

Working with patient associations: What is the key to a positive interaction?

Last updated: April 13, 2026

What rare disease patients and families want is a simpler life.
Discover here what makes the relationship between the members of the patients’ association and a company work so well.

Subscribe to our newsletter

Turning neuroscience trial complexity into meaningful clinical evidence with eCOA

From passive sensors to patient voice: the value of integrating...

Advancing oncology research: the crucial role of patient-reported outcomes in...

6 Best Practices for Accelerating eCOA Study Start-Up Timelines

How Kayentis Delivered eCOA Go-Live in Just 5 Weeks for...

Turning endpoint noise into reliable CNS trial data

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events